Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes.
Varney L, Murtough S, Cotic M, Abidoph R, Chan L, Saadullah Khani N, Richards-Belle A, Richards-Brown M, Mills D, Panconesi D, Dawda Y, Sharma P, Shah C, Secchi A, Nilforooshan R, Mudholkar S, Murdoch R, Molai J, Griffiths R, Senthilkumar S, Blake H, Lankshear S, McRoberts J, Pastor B, Thomas C, Richards S, Welfare-Wilson A, Cheung SB, Cox R, Jibero AC, Anad R, Laczik R, Ghali S, Berry AJ, Curwen J, Odutoye K, Kottalgi G, Williams S, Wong S, Anandan N, Pius G, Ajiteru T, Clark V, van Driel P, Bashir A, Court S, Pawsey M, Skowronska A, Woodley J, Bramon E.
Varney L, et al.
Pharmaceuticals (Basel). 2025 Jun 14;18(6):892. doi: 10.3390/ph18060892.
Pharmaceuticals (Basel). 2025.
PMID: 40573287
Free PMC article.